PLSE logo

Pulse Biosciences, Inc. (PLSE) Cash from operations

annual CFO:

-$36.34M-$3.30M(-9.99%)
December 31, 2024

Summary

  • As of today (August 22, 2025), PLSE annual cash flow from operations is -$36.34 million, with the most recent change of -$3.30 million (-9.99%) on December 31, 2024.
  • During the last 3 years, PLSE annual CFO has risen by +$17.75 million (+32.82%).
  • PLSE annual CFO is now -995.66% below its all-time high of -$3.32 million, reached on December 31, 2015.

Performance

PLSE Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPLSEcash flow metrics

quarterly CFO:

-$12.81M+$714.00K(+5.28%)
June 30, 2025

Summary

  • As of today (August 22, 2025), PLSE quarterly cash flow from operations is -$12.81 million, with the most recent change of +$714.00 thousand (+5.28%) on June 30, 2025.
  • Over the past year, PLSE quarterly CFO has dropped by -$4.41 million (-52.56%).
  • PLSE quarterly CFO is now -2702.41% below its all-time high of -$457.00 thousand, reached on March 31, 2015.

Performance

PLSE quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPLSEcash flow metrics

TTM CFO:

-$44.50M-$4.41M(-11.01%)
June 30, 2025

Summary

  • As of today (August 22, 2025), PLSE TTM cash flow from operations is -$44.50 million, with the most recent change of -$4.41 million (-11.01%) on June 30, 2025.
  • Over the past year, PLSE TTM CFO has dropped by -$9.05 million (-25.54%).
  • PLSE TTM CFO is now -9636.54% below its all-time high of -$457.00 thousand, reached on March 31, 2015.

Performance

PLSE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPLSEcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

PLSE Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.0%-52.6%-25.5%
3 y3 years+32.8%+0.1%+18.3%
5 y5 years-6.3%-61.3%-28.1%

PLSE Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.0%+32.8%-94.9%+5.3%-34.7%+18.3%
5 y5-year-10.0%+32.8%-94.9%+21.8%-34.7%+23.3%
alltimeall time-995.7%+32.8%-2702.4%+21.8%-9636.5%+23.3%

PLSE Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$12.81M(-5.3%)
-$44.50M(+11.0%)
Mar 2025
-
-$13.52M(+47.9%)
-$40.08M(+10.3%)
Dec 2024
-$36.34M(+10.0%)
-$9.14M(+1.3%)
-$36.34M(+7.0%)
Sep 2024
-
-$9.02M(+7.5%)
-$33.98M(-4.1%)
Jun 2024
-
-$8.39M(-14.2%)
-$35.44M(-2.2%)
Mar 2024
-
-$9.78M(+44.3%)
-$36.25M(+9.7%)
Dec 2023
-$33.04M(-29.7%)
-$6.78M(-35.4%)
-$33.04M(-3.5%)
Sep 2023
-
-$10.49M(+14.0%)
-$34.23M(-0.4%)
Jun 2023
-
-$9.20M(+40.1%)
-$34.37M(-9.5%)
Mar 2023
-
-$6.57M(-17.5%)
-$37.99M(-19.2%)
Dec 2022
-$47.01M(-13.1%)
-$7.96M(-25.1%)
-$47.01M(-9.1%)
Sep 2022
-
-$10.63M(-17.1%)
-$51.74M(-5.0%)
Jun 2022
-
-$12.82M(-17.8%)
-$54.46M(-6.1%)
Mar 2022
-
-$15.59M(+22.8%)
-$58.00M(+7.2%)
Dec 2021
-$54.10M(+53.0%)
-$12.69M(-4.9%)
-$54.10M(+6.8%)
Sep 2021
-
-$13.35M(-18.4%)
-$50.66M(+10.5%)
Jun 2021
-
-$16.37M(+40.0%)
-$45.86M(+22.5%)
Mar 2021
-
-$11.69M(+26.3%)
-$37.43M(+5.8%)
Dec 2020
-$35.37M
-$9.26M(+8.3%)
-$35.37M(+0.2%)
Sep 2020
-
-$8.55M(+7.7%)
-$35.31M(+1.7%)
Jun 2020
-
-$7.94M(-17.5%)
-$34.72M(-4.8%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$9.62M(+4.6%)
-$36.48M(+6.7%)
Dec 2019
-$34.19M(+43.1%)
-$9.20M(+15.5%)
-$34.19M(+9.2%)
Sep 2019
-
-$7.96M(-17.8%)
-$31.30M(+3.7%)
Jun 2019
-
-$9.69M(+32.3%)
-$30.18M(+15.2%)
Mar 2019
-
-$7.33M(+16.2%)
-$26.21M(+9.7%)
Dec 2018
-$23.90M(+115.5%)
-$6.31M(-7.9%)
-$23.90M(+10.9%)
Sep 2018
-
-$6.85M(+19.8%)
-$21.55M(+18.9%)
Jun 2018
-
-$5.72M(+14.0%)
-$18.12M(+33.2%)
Mar 2018
-
-$5.02M(+26.6%)
-$13.61M(+22.7%)
Dec 2017
-$11.09M(+37.7%)
-$3.96M(+16.0%)
-$11.09M(+17.4%)
Sep 2017
-
-$3.42M(+182.9%)
-$9.44M(+17.9%)
Jun 2017
-
-$1.21M(-51.7%)
-$8.01M(-11.9%)
Mar 2017
-
-$2.50M(+7.8%)
-$9.09M(+12.9%)
Dec 2016
-$8.05M(+142.7%)
-$2.32M(+17.0%)
-$8.05M(+14.0%)
Sep 2016
-
-$1.98M(-13.4%)
-$7.06M(+17.2%)
Jun 2016
-
-$2.29M(+56.6%)
-$6.03M(+39.5%)
Mar 2016
-
-$1.46M(+9.9%)
-$4.32M(+30.3%)
Dec 2015
-$3.32M
-$1.33M(+40.3%)
-$3.32M(+66.9%)
Sep 2015
-
-$948.00K(+62.9%)
-$1.99M(+91.2%)
Jun 2015
-
-$582.00K(+27.4%)
-$1.04M(+127.4%)
Mar 2015
-
-$457.00K
-$457.00K

FAQ

  • What is Pulse Biosciences, Inc. annual cash flow from operations?
  • What is the all time high annual CFO for Pulse Biosciences, Inc.?
  • What is Pulse Biosciences, Inc. annual CFO year-on-year change?
  • What is Pulse Biosciences, Inc. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Pulse Biosciences, Inc.?
  • What is Pulse Biosciences, Inc. quarterly CFO year-on-year change?
  • What is Pulse Biosciences, Inc. TTM cash flow from operations?
  • What is the all time high TTM CFO for Pulse Biosciences, Inc.?
  • What is Pulse Biosciences, Inc. TTM CFO year-on-year change?

What is Pulse Biosciences, Inc. annual cash flow from operations?

The current annual CFO of PLSE is -$36.34M

What is the all time high annual CFO for Pulse Biosciences, Inc.?

Pulse Biosciences, Inc. all-time high annual cash flow from operations is -$3.32M

What is Pulse Biosciences, Inc. annual CFO year-on-year change?

Over the past year, PLSE annual cash flow from operations has changed by -$3.30M (-9.99%)

What is Pulse Biosciences, Inc. quarterly cash flow from operations?

The current quarterly CFO of PLSE is -$12.81M

What is the all time high quarterly CFO for Pulse Biosciences, Inc.?

Pulse Biosciences, Inc. all-time high quarterly cash flow from operations is -$457.00K

What is Pulse Biosciences, Inc. quarterly CFO year-on-year change?

Over the past year, PLSE quarterly cash flow from operations has changed by -$4.41M (-52.56%)

What is Pulse Biosciences, Inc. TTM cash flow from operations?

The current TTM CFO of PLSE is -$44.50M

What is the all time high TTM CFO for Pulse Biosciences, Inc.?

Pulse Biosciences, Inc. all-time high TTM cash flow from operations is -$457.00K

What is Pulse Biosciences, Inc. TTM CFO year-on-year change?

Over the past year, PLSE TTM cash flow from operations has changed by -$9.05M (-25.54%)
On this page